Viveve (NSDQ:VIVE) said today it inked 6 new distribution deals to expand the availability of its Viveve non-surgical treatment for post-partum laxity of the vaginal introitus to 14 Latin American countries. The women’s health company said it inked deals with Sirex S.A., Torregal, Alphaeon Columbia S.A.S., Vitre-Tech, Coolmed S.A., Adenor S.A. and MARC Group International to bring […]
Women's Health
SonoSim, GE Healthcare re-up ultrasound training deal
Ultrasound education focused SonoSim said this week it is extending a collaboration with GE Healthcare (NYSE:GE) to cover ultrasound training and education for GE’s women’s health and urology divisions. Through the extended collaboration, Sonosim will offer its SonoSim 365 for GE Healthcare to clients in the women’s health and urology fields who own qualifying ultrasound systems […]
U.K. launches study of Dune Medical’s MarginProbe breast cancer device
Dune Medical Devices said this week that the U.K.’s National Health Service is launching a study of its MarginProbe device, which is designed to spot cancerous cells on the margins of breast tumors. Paoli, Pa.-based Dune said the NHS’s National Institute of Health Research arm is funding a study to see whether MarginProbe reduces the need for further re-excision […]
Viveve closes $16m uplisting
Viveve (NSDQ:VIVE) said today that its uplisting to the NASDAQ exchange grossed $15.5 million, including an unwriters over-allotment. Sunnyvale, Calif.-based Viveve, which makes a non-surgical treatment for post-partum laxity of the vaginal introitus, said it sold more than 3.1 million shares at $5 apiece, for net proceeds of about $14 million. Earlier this week Viveve tweaked the value […]
Viveve ups share count, lowers share price in $13.5m NASDAQ uplisting
Viveve (OTC:VIVMD) today tweaked the value of its uplisting from the over-the-counter exchange to the NASDAQ board, expecting to sell 2.7 million shares at $5 per share to bring in $13.5 million. Sunnyvale, Calif.-based Viveve makes a non-surgical treatment for post-partum laxity of the vaginal introitus. The company put a 1-for-8 reverse split into place in April, and said […]
Boston Scientific updates warnings for pelvic mesh products
Boston Scientific (NYSE:BSX) recently updated the directions for use and warnings for its pelvic mesh products, classifying the meshes as permanent implants and warning of complications related to removals. The Marlborough, Mass.-based company added new precautions to the directions for the meshes, warning that that “regardless of the route of delivery,” the meshes have been associated with […]
Ethicon mesh plaintiffs claim company expert admitted mesh degrades
Plaintiffs in the multi-district litigation brought over the pelvic mesh made by Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon claimed this week that a company expert admitted that Ethicon knew back in 1992 that the plastic used in its mesh degrades after implantation. The case concerns damages reportedly caused by Ethicon’s pelvic mesh products. Plaintiffs in […]
Guided Therapeutics inks Chinese Luviva licensing deal
Guided Therapeutics (OTC:GTHP) said today it inked a licensing deal with Shenghuo Medical to manufacture and market its LuViva advanced cervical scan system in China and several other Southeast Asian countries. The deal includes $200,000 in near-term cash payments, up to $1 million to support FDA approval for LuViva and extra support for achieving Chinese regulatory approval […]
Mirabilis Medica raises $5.2m for uterine fibroid treating device
Uterine fibroid-treating device developer Mirabilis Medica raised $5.2 million in a new round of debt financing, according to an SEC filing posted today. The company’s Mirabilis system is designed to use ultrasound to both provide imaging and ablation during procedures to remove uterine fibroids, the company said. The device uses low-intensity ultrasound waves to locate […]
FDA clears Esco Medical’s Miri TL embryo incubator
In vitro fertilization business Esco Medical said today the FDA granted 510(k) clearance to its Miri Time-Lapse embryo incubator. The newly cleared Miri TL is designed as a multi-room incubator with a built-in microscope and camera to continuously capture images of embryo development until the embryo is ready to transfer, the company said. “We are […]
OvaScience closes $53.8m financing round
OvaScience (NSDQ:OVAS) said today it closed a $53.8 million funding round as it looks to expand its Augment treatment in Japan and Canada and support pre-commercial activities for its OvaPrime and OvaTure treatments. OvaScience’s Augment fertility treatment is designed to enhance in vitro fertilization by improving the health of a woman`s eggs, the company said. The treatment draws […]